Skip to main content

Table 2 Overview CMR results

From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach

 

MD

Controls

p value

N = 63

N = 26

LV-EDVi, ml/m2

85 ± 30

86 ± 16

0.80

LV-ESVi, ml/m2

41 ± 21

31 ± 9

0.003

LV-massi, g/m2

60 ± 16

58 ± 10

0.69

LV-EF, %

53 ± 12

64 ± 6

<0.0001

RV-EF, %

53 ± 9

55 ± 8

0.47

LV-EF <55 %, n (%)

29 (46)

0 (0)

<0.0001

RV-EF <45 %, n (%)

10 (16)

0 (0)

0.031

LGE presence, n (%)

48 (76)

0 (0)

<0.0001

LGE extent, %

7 (1-17)

-

-

Abnormal CMR, n (%)

49 (78)

0 (0)

<0.0001

  1. Bold text indicates a significant p-value of <0.05
Back to article page

Journal of Cardiovascular Magnetic Resonance

ISSN: 1532-429X

Contact us